ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma
Clinical trial NCT02858258 · UNKNOWN
Trial details
- NCT number
- NCT02858258
- Sponsor
- Prof. Dr. M. Dreyling (co-chairman)
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2021-05-01
- Enrollment
- 870
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.